ESMO - European Society for Medical Oncology

🤖 #ESMOAI26: From innovation to real-world impact in oncology. Artificial intelligence is opening new possibilities across cancer research and clinical practice. But how do we move from technological promise to meaningful, safe, and effective implementation? Join professionals at the forefront of AI & Digital Oncology to explore the latest scientific and technological advances, multidisciplinary innovation, ethical and regulatory challenges, and the real-world implementation of AI in oncology. Discover how to critically evaluate emerging autonomous and agentic AI systems, understand human–AI interaction, and help shape responsible adoption across research and clinical workflows. Late registration closes on 28 October. Secure your place today and be part of the conversation shaping the future of oncology.

📢 Connect with leading experts in immuno-oncology and advanced therapies. Register now and benefit from the early registration fees. ⏰ Deadline: 14 October 2026, 21:00 CEST.

👉 Abstract submission is open. Share your latest research in genitourinary cancers with a regional and international community of oncology experts. ⏰ Deadline: 13 October 2026.

👉 Abstract submission is open. Share your latest findings with a global audience of immuno-oncology and advanced therapies experts. ⏰ Deadline: 22 September 2026.

📢 Leave a mark on oncology. Become an ESMO #EditorInChief. 🌟 If advancing science, inspiring researchers and contributing to the future of #CancerCare are drivers of your professional commitment, this is your opportunity to make a lasting impact. ESMO is expanding its journal portfolio with three new titles: we are looking for visionary leaders ready to contribute their expertise, knowledge and experience to the global oncology community. Applications are now open for Editor-in-Chief positions for: ➡️ ESMO Genitourinary Oncology ➡️ ESMO Oncology Policy and Science ➡️ ESMO Artificial Intelligence and Oncology As Editor-in-Chief, your role will be key to fostering the same scientific excellence that underpins all ESMO journals and to guiding the publication of #CancerResearch that drives progress in patient care worldwide. 📅 Apply by 6 September 2026 📍 Learn more about the positions on our website

📢 #ESMOGynae26 : When new standards of care are discussed, you want to be in the room. More than 50% increase in abstract submissions means stimulating discussions working towards shaping the future of patient care—from biomarkers and precision medicine to novel therapeutic strategies. This is where leaders in gynaecological oncology share practice-changing data and research meets real-world impact. Explore the latest in: • Targeted therapies and ADCs in ovarian cancer • Advances in cervical and endometrial cancer management • Biomarkers driving precision medicine • Bench-to-bedside innovation This is not just another congress—it’s where clinical practice evolves.